Literature DB >> 8964822

A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyperthyroidism.

N de Roux1, M Polak, J Couet, J Leger, P Czernichow, E Milgrom, M Misrahi.   

Abstract

Until recently, neonatal hyperthyroidism has been considered to be related to the transplacental passage of thyroid-stimulating Ig present in the serum of the mother. We report here the case of a newborn who presented with severe hyperthyroidism, diffuse goiter, and important ocular signs (eyelid retraction and possibly proptosis). However, the absence of thyroid pathology in the parents and the lack of antithyroid antibodies in the mother and in the patient led us to suspect a nonimmune aetiology. Direct genomic sequencing of the last exon of the TSH receptor in the patient revealed a T-->C transversion yielding to a Met453-->Thr heterozygous substitution in the second transmembrane domain of the receptor. The mutation was absent in both parents. Eukaryotic expression analysis in COS-7 cells yielded a mutated receptor that produced constitutive activation of adenylate cyclase without enhancement of phospholipase C activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8964822     DOI: 10.1210/jcem.81.6.8964822

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

Review 1.  Thyrotropin receptor mutations in thyroid diseases.

Authors:  P M Yen
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

2.  Sporadic nonautoimmune neonatal hyperthyroidism due to A623V germline mutation in the thyrotropin receptor gene.

Authors:  Zehra Aycan; Sebahat Yılmaz Ağladıoğlu; Serdar Ceylaner; Semra Cetinkaya; Veysel Nijat Baş; Havva Nur Peltek Kendirici
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-11-07

Review 3.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

Review 4.  Molecular insights into TSH receptor abnormality and thyroid disease.

Authors:  D Russo; F Arturi; E Chiefari; S Filetti
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

5.  Congenital hyperthyroidism caused by a solitary toxic adenoma harboring a novel somatic mutation (serine281-->isoleucine) in the extracellular domain of the thyrotropin receptor.

Authors:  P Kopp; S Muirhead; N Jourdain; W X Gu; J L Jameson; C Rodd
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

6.  2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations.

Authors:  R Paschke; M Niedziela; B Vaidya; L Persani; B Rapoport; J Leclere
Journal:  Eur Thyroid J       Date:  2012-10-04

7.  Genetic analysis of the TSH receptor gene in differentiated human thyroid carcinomas.

Authors:  F Cetani; M Tonacchera; A Pinchera; R Barsacchi; F Basolo; P Miccoli; F Pacini
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

8.  Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism.

Authors:  J Lueblinghoff; S Mueller; J Sontheimer; R Paschke
Journal:  J Endocrinol Invest       Date:  2009-07-28       Impact factor: 4.256

Review 9.  Hyperplasia in glands with hormone excess.

Authors:  Stephen J Marx
Journal:  Endocr Relat Cancer       Date:  2015-09-25       Impact factor: 5.678

10.  A family with a novel TSH receptor activating germline mutation (p.Ala485Val).

Authors:  Sema Akcurin; Doga Turkkahraman; Carolyn Tysoe; Sian Ellard; Anne De Leener; Gilbert Vassart; Sabine Costagliola
Journal:  Eur J Pediatr       Date:  2008-01-04       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.